The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment

Ina Patties, Annegret Glasow|Journal of Experimental & Clinical Cancer Research|2019

Cited by 42